Jennifer Amengual – New Associate Editor for Blood Neoplasia!
Blood Journals Portfolio shared on LinkedIn:
”We are delighted to introduce Dr. Jennifer Amengual, new Associate Editor for Blood Neoplasia!
Dr. Amengual is an Associate Professor of Medicine at Columbia University Irving Medical Center and a physician-scientist whose research focuses on developing targeted therapies for patients with lymphoma.
Her work has advanced our understanding of epigenetic and transcriptional pathways in germinal center–derived B-cell and T-cell lymphomas, as well as strategies to predict, prevent, and treat post-transplant lymphoproliferative disorders.
Beyond her research, Dr. Amengual is a dedicated mentor and an active member of American Society of Hematology, contributing to programs such as CRTI, TRTH, and the Hematology Review Series.
She has also led impactful clinical trials through ETCTN/CTEP, SWOG, and investigator-initiated studies.
Please join us in welcoming Dr. Amengual to the Blood Neoplasia team.”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 08:20Cory Dugan: The IRONWOMAN Trial Individual Responses to IV Iron Therapy in Active Women
-
Oct 19, 2026, 07:36Johannes Kaesmacher: Cerebral No-Reflow After Thrombectomy Toward a Standardized Definition
-
Oct 19, 2026, 07:33Beth Psaila: Highlights from IACH Annual Meeting and MPN Horizons
-
Oct 19, 2026, 07:29Wolfgang Miesbach: Can Losartan Activate Brown Fat? – Nature Study Explores New Therapeutic Link
-
Oct 19, 2026, 07:22Ruben Mesa: Honored to Speak at the Tandem MPN Meetings of IACH
-
Oct 19, 2026, 07:19Saneha Anjum Shaikh: Parul University Partners with Raktasevak Bike Ride 2026 for Blood Donation Drive
-
Oct 19, 2026, 07:09Alejandro González Veliz: No ST Elevation Does Not Guarantee an Open Coronary Artery
-
Oct 19, 2026, 06:02Thomas Dayspring: Vascular Resilience – What Is It and How Can We Measure It?
-
Oct 19, 2026, 05:53Kevon Dindial: Collaboration for Better Childhood Cancer Outcomes